MEDI-1814 is a fully human IgG1 antibody that targets the C terminus of Abeta42. MEDI-1814 binds to and sweeps away the circulated Abeta peptides, hence, restricting them from aggregating into toxic oligomers. MEDI-1814 can be used for the study of Alzheimers diseases. The isotype control for MEDI-1814 can refer to Human IgG1 kappa, Isotype Control (HY-P99001)[1].
Target:
Amyloid-beta
Application Notes:
Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
